Pliant Therapeutics, Inc. · NASDAQ:PLRX
T. Rowe Price Associates Inc's stake in Pliant Therapeutics, Inc. fell to 0.10% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
T. Rowe Price Associates Inc's stake in Pliant Therapeutics, Inc. fell to 0.10%, 87,674 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 0.10%
- Shares
- 87,674
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 0.10% | 87,674 |
Source
Related
- Pliant Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026